Search

Search Constraints

You searched for: Author/Creator Mak, Elijah

Search Results

11. [P1–462]: [11C]PK11195 PET IMAGING REVEALS NEUROINFLAMMATION IN DEMENTIA WITH LEWY BODIES IS NEGATIVELY ASSOCIATED WITH DISEASE SEVERITY: NIMROD STUDY. (1st July 2017)

12. [P2–358]: IN VIVO MAPPING OF TAU DEPOSITION, PERFUSION, AND CORTICAL THINNING IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE. (1st July 2017)

13. [P3–403]: [11C]PK11195 PET IN ALZHEIMER's DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY: THE NIMROD STUDY. (1st July 2017)

14. [P4–220]: LONGITUDINAL DIFFUSION TENSOR IMAGING AS A PREDICTOR OF COGNITIVE DOMAIN DECLINE IN EARLY‐STAGE PARKINSON's DISEASE: ICICLE‐PD STUDY. (1st July 2017)

15. Amyloid and tau deposition influences cognitive decline in Down syndrome. (31st December 2021)

16. Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid‐positive mild cognitive impairment is associated with key clinical features. Issue 1 (1st December 2019)

17. CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study. Issue 5 (8th February 2022)

20. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy. Issue 6 (25th January 2022)